Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

NCT ID: NCT06386198Sponsor: University of California, San FranciscoLast updated: 2025-05-13

Summary

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Arms & interventions

  • BehavioralHealth Advocate

    The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.

Outcome measures

Primary

  • Changes in patient experience

    The investigators will administer a survey of patient experience at study enrollment and at the end of the intervention to assess for changes in patient experience with the transplant team. These questions will focus on experiences receiving transplant care, experiences discussing social needs with the transplant team, and overall subjective assessment of the transplant recipient's overall health.

    Time frame: Baseline and 180 days

Secondary

  • Change in medication adherence using MLVI

    Time frame: Baseline and 180 days

  • The quality of health advocate interactions with the participants, healthcare team, and community-based resources.

    Time frame: 180 days

  • A qualitative assessment of patient and healthcare provider satisfaction with the Health Advocate intervention.

    Time frame: 180 days

Eligibility criteria

Sex: AllAge: 18 Years to 25 YearsHealthy volunteers: No
Inclusion Criteria: 1. Patient has received a liver transplant \>1 year ago 2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program. 3. Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0. 4. Patient will be transferred to adult transplant team in \<6 months. 5. Patient can read and write English or Spanish 6. Patient is between 18-25 years old and can provide informed consent. 7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom. Exclusion Criteria: * Patient has significant cognitive impairment. * Does not meet age criteria * Patient is a ward of the state. * Non-English, non-Spanish speakers. * Non-US residents.

Study locations (2)

University of California San Francisco

San Francisco, California, 94158

Recruiting
Emily Stekol · Contact
415-502-3190emily.stekol@ucsf.edu
Sharad Wadhwani, MD, MPH · Principal Investigator

Children's Healthcare of Atlanta

Atlanta, Georgia, 30345

Not Yet Recruiting
Nitika Gupta · Contact
Nitika Gupta · Principal Investigator